1.Annexin A2 and pathogenesis of cancer: an update.
Chinese Journal of Pathology 2007;36(2):129-132
2.Laryngeal pleomorphic rhabdomyosarcoma: report of a case.
Chinese Journal of Pathology 2007;36(8):573-574
Adult
;
Diagnosis, Differential
;
Histiocytoma, Malignant Fibrous
;
pathology
;
Humans
;
Laryngeal Neoplasms
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Laryngectomy
;
Leiomyosarcoma
;
pathology
;
Male
;
Rhabdomyosarcoma
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Tomography, X-Ray Computed
;
Vimentin
;
metabolism
3.Advances in poorly differentiated thyroid carcinoma.
Jian SUN ; Di YANG ; Quan-cai CUI
Chinese Journal of Pathology 2011;40(12):850-853
Adenocarcinoma, Follicular
;
epidemiology
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Papillary
;
pathology
;
DNA-Binding Proteins
;
metabolism
;
Diagnosis, Differential
;
Genes, ras
;
genetics
;
Humans
;
Point Mutation
;
Prognosis
;
Thyroglobulin
;
metabolism
;
Thyroid Neoplasms
;
epidemiology
;
genetics
;
metabolism
;
pathology
;
Transcription Factors
4.Gastrointestinal tract access of enteral nutrition in 2092 patients
Dawei CHEN ; Long CUI ; Zhiwei QUAN ; Peng DU
Chinese Journal of Clinical Nutrition 2009;17(3):141-143
s of enteral nutrition depends on the primary diseases and duration of nutmition support.Nasoenteral tube placement is safe and effective.Percutaneons endoscopic gastrostomy and needle catheter jejunostomy are the alternative approaches.
6.Clinical study on relationship between protein tyrosine kinase JAK2 V617F mutation and high altitude polycythemia.
Lin-hua JI ; Zhan-quan LI ; Sen CUI
Chinese Journal of Hematology 2012;33(4):319-320
Adult
;
Aged
;
Altitude
;
Humans
;
Janus Kinase 2
;
genetics
;
Male
;
Middle Aged
;
Point Mutation
;
Polycythemia
;
genetics
7.Proteomics and its applications in the research of papillary thyroid carcinoma.
Jie SHI ; Zhao-hui LU ; Quan-cai CUI
Chinese Journal of Pathology 2007;36(10):691-693
Biomarkers, Tumor
;
metabolism
;
Carcinoma, Papillary
;
metabolism
;
Cathepsin B
;
metabolism
;
Cell Cycle Proteins
;
metabolism
;
HSP27 Heat-Shock Proteins
;
metabolism
;
Humans
;
Proteomics
;
Repressor Proteins
;
metabolism
;
S100 Calcium Binding Protein A6
;
S100 Proteins
;
metabolism
;
Serpins
;
metabolism
;
Thyroid Neoplasms
;
metabolism
8.Survey on the symptoms and risk factors in patients with hypertension.
Wen-quan ZHOU ; Xiang-dong YU ; Ling CUI
Chinese Journal of Integrated Traditional and Western Medicine 2002;22(6):457-458
Adult
;
Aged
;
Cerebral Infarction
;
etiology
;
China
;
epidemiology
;
Coronary Disease
;
diagnosis
;
etiology
;
Diagnosis, Differential
;
Female
;
Humans
;
Hypertension
;
complications
;
diagnosis
;
epidemiology
;
Logistic Models
;
Male
;
Medicine, Chinese Traditional
;
Middle Aged
;
Risk Factors
;
Yin Deficiency
;
diagnosis
10.Mechanism of aqueous humor through uveoscleral outflow in rabbits with topical administration of moxonidine
Jiangang YANG ; Lijun CUI ; Yanlong QUAN ; Xiaohua WANG ; Shiping ZHAO
Journal of Xi'an Jiaotong University(Medical Sciences) 1982;0(01):-
Objective To investigate the changes of uveoscleral pathway by an I1 receptor agonist,moxonidine,and with pretreatment of antagonists topical administration,and to study the mechanism that moxonidine improves uveoscleral outflow.Methods Moxonidine was administered unilaterally and topically to rabbits and with pretreatment of the antagonists,namely,prazosin,yohimbine and efaroxan.FITC-BSA,a tracer agent,was injected into the anterior chamber after moxonidine treatment or with pretreatment of the antagonists.Frozen sections were undertaken at different time points between 2 to 10 h.Fluorescence intensity was observed in the sites of uveoscleral pathway in the sections by fluorescence microscopy.Results Bilateral fluorescence intensity treated with moxonidine was more intense than that with placebo,and the most intense regions of fluorescence were ciliary body and superchoroidal space.Fluorescence intensity by prazosin pretreatment was not significantly different compared to that by moxonidine,while yohimbine and efaroxan pretreatment decreased the intensity compared with moxonidine(P